| P2093 | author name string | Andrew J Wilson | |
| | Dineo Khabele | |
| | Deok-Soo Son | |
| | Angelika K Parl | |
| P2860 | cites work | Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase | Q24563699 |
| | The many roles of histone deacetylases in development and physiology: implications for disease and therapy | Q24628821 |
| | Aspirin induces apoptosis through the inhibition of proteasome function | Q28199915 |
| | Extracellular signal-regulated kinase is a target of cyclooxygenase-1-peroxisome proliferator-activated receptor-delta signaling in epithelial ovarian cancer | Q28212231 |
| | Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors | Q29547463 |
| | Cancer statistics, 2009 | Q29547625 |
| | Anticancer activities of histone deacetylase inhibitors | Q29616624 |
| | Combined histone deacetylase and NF-kappaB inhibition sensitizes non-small cell lung cancer to cell death | Q30434141 |
| | A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study | Q30445663 |
| | Nonsteroidal anti-inflammatory drugs and risk for ovarian and endometrial cancers in the Iowa Women's Health Study | Q33645700 |
| | Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation. | Q34268195 |
| | Cancer of the ovary | Q34375262 |
| | Histone deacetylase inhibitors: signalling towards p21cip1/waf1. | Q36782509 |
| | Expression of class I histone deacetylases indicates poor prognosis in endometrioid subtypes of ovarian and endometrial carcinomas | Q36840303 |
| | Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer | Q36975194 |
| | Depsipeptide (FK228) as a novel histone deacetylase inhibitor: mechanism of action and anticancer activity | Q36990556 |
| | Early events in the pathogenesis of epithelial ovarian cancer | Q37057044 |
| | Mutation analysis of 24 known cancer genes in the NCI-60 cell line set. | Q37250634 |
| | Enhancing the apoptotic and therapeutic effects of HDAC inhibitors | Q37440094 |
| | Histone deacetylase inhibitors and aspirin interact synergistically to induce cell death in ovarian cancer cells. | Q39968749 |
| | Tumor necrosis factor-alpha related gene response to Epothilone B in ovarian cancer | Q40572985 |
| | Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer | Q44342271 |
| | Dietary aspirin decreases the stage of ovarian cancer in the hen. | Q46262682 |
| | Cyclooxygenase-1 is overexpressed in multiple genetically engineered mouse models of epithelial ovarian cancer. | Q46970864 |
| | Drug-induced inactivation or gene silencing of class I histone deacetylases suppresses ovarian cancer cell growth: implications for therapy. | Q53563335 |
| | Ovarian cancer | Q80994319 |
| P433 | issue | 11 | |
| P921 | main subject | ovarian cancer | Q172341 |
| | aspirin | Q18216 |
| P304 | page(s) | 928-935 | |
| P577 | publication date | 2010-06-25 | |
| P1433 | published in | Cancer Biology and Therapy | Q2544651 |
| P1476 | title | The effects of the histone deacetylase inhibitor romidepsin (FK228) are enhanced by aspirin (ASA) in COX-1 positive ovarian cancer cells through augmentation of p21 | |
| P478 | volume | 9 | |